REQUEST A DEMO
Total
USD $0.00
Search more companies

Ioosab AO (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing
Full name: Irkutskaya Oblastnaya Optovo-Snabzhencheskaya Aptechnaya Baza AO Profile Updated: March 07, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

Ioosab AO is based in Russia. The head office is in Irkutsk. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on January 23, 2006. Ioosab AO currently employs 101 (2022) people. There was a net sales revenue drop of 20.74% reported in Ioosab AO’s latest financial highlights for 2022. There was a total growth of 14.61% in Ioosab AO’s total assets over the same period. The net profit margin of Ioosab AO increased by 0.17% in 2022.

Headquarters
Ulitsa Tuhachevskogo, 3
Irkutsk; Irkutsk Oblast; Postal Code: 664040

Contact Details: Purchase the Ioosab AO report to view the information.

Website: http://apbase.ru

Basic Information
Total Employees:
Purchase the Ioosab AO report to view the information.
Outstanding Shares:
Purchase the Ioosab AO report to view the information.
Registered Capital:
Purchase the Ioosab AO report to view the information.
Incorporation Date:
January 23, 2006
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Fitomed
25%
Regionalnyi Fond Razvitie Priangarya
Company Performance
Financial values in the chart are available after Ioosab AO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-20.74%
Total operating revenue
-20.74%
Operating profit (EBIT)
-56.18%
Net Profit (Loss) for the Period
-12.59%
Total assets
14.61%
Total equity
13.84%
Operating Profit Margin (ROS)
-0.83%
Net Profit Margin
0.17%
Return on Equity (ROE)
-6.31%
Quick Ratio
-0.64%
Cash Ratio
-0.78%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?